Published Date: 5-Nov-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Myomectomy Market, published by KBV research, The Global Myomectomy Market size is expected to reach $895.8 Million by 2026, rising at a market growth of 13.6% CAGR during the forecast period.
The abdominal myomectomy segment led the market in the year 2019. This is due to the growing number of uterine fibroids patients, which demands myomectomy procedures for the treatment of these diseases. This procedure is also the most done and extensively favored treatment for fibroids. The laparoscopic myomectomy segment is anticipated to show the highest CAGR in the coming years. The technique involves less invasive procedures and faster recovery patients as compared to usual myomectomy procedures.
North America has the largest market of myomectomy due to the presence of main players in the healthcare IT industry in this region. Europe holds second place in having the largest market for myomectomy. there is a growing demand for medical devices in Europe and also governments of these countries are releasing more funds for research and development activities related to reproductive health. The market in the Asia Pacific is likely to grow at the fastest speed and it is due to the increasing women who are affected by uterine disorders, and intensifying investment in the industry of surgical devices by main players in developing countries throughout Asia Pacific. China, India, and Japan are the main contributors to market growth.
Structural Insights: https://www.kbvresearch.com/myomectomy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Stryker Corporation, Johnson and Johnson, Hologic, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, ConMed Corporation, Intuitive Surgical, Inc., The Cooper Companies, Inc., and Minerva Surgical, Inc.
Unique Offerings from KBV Research